Terms: = Kidney tumors AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
122 results:
1. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing.
Weng KQ; Liu JY; Li H; She LL; Qiu JL; Qi H; Qi HY; Li YS; Dai YB
Int Immunopharmacol; 2024 Mar; 130():111746. PubMed ID: 38442575
[TBL] [Abstract] [Full Text] [Related]
3. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract] [Full Text] [Related]
4. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Expression and Prognostic Implications of Krüppel-Like Factor 3 (KLF3) in Clear Cell Renal Cell Carcinoma.
Wan B; Zhang W; Deng X; Lu Y; Zhang Z; Yang Y
Crit Rev Eukaryot Gene Expr; 2024; 34(2):45-59. PubMed ID: 38073441
[TBL] [Abstract] [Full Text] [Related]
6. Abnormal expression of FOXM1 in carcinogenesis of renal cell carcinoma: From experimental findings to clinical applications.
Shan Y; Zheng L; Zhang S; Qian B
Biochem Biophys Res Commun; 2024 Jan; 692():149251. PubMed ID: 38056162
[TBL] [Abstract] [Full Text] [Related]
7. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract] [Full Text] [Related]
8. Identification of circATG9A as a novel biomarker for renal cell carcinoma.
Shen Y; Wu R; Zhuo Z; Deng X; Li W; Liu C
Cancer Gene Ther; 2024 Jan; 31(1):82-93. PubMed ID: 37945969
[TBL] [Abstract] [Full Text] [Related]
9. Identification of key genes and validation of key gene aquaporin 1 on Wilms' tumor metastasis.
Liu H; Jin C; Yang X; Xia N; Guo C; Dong Q
PeerJ; 2023; 11():e16025. PubMed ID: 37904849
[TBL] [Abstract] [Full Text] [Related]
10. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
[TBL] [Abstract] [Full Text] [Related]
11. Pan-cancer analysis reveals the prognostic gene CASR suppresses tumor progression and epithelial-mesenchymal transition in renal clear cell carcinoma.
Zhou Z; Feng D; Yang Y; Gao P; Wang L; Wu Z
Cell Calcium; 2023 Dec; 116():102803. PubMed ID: 37804688
[TBL] [Abstract] [Full Text] [Related]
12. Circ-PGPEP1 augments renal cell carcinoma proliferation, Warburg effect, and distant metastasis.
Wang P; Chen J; Ye X; Wang R; Chen L; Zhang H
Acta Biochim Pol; 2023 Sep; 70(3):703-711. PubMed ID: 37722013
[TBL] [Abstract] [Full Text] [Related]
13. Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.
Korbecki J; Bosiacki M; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686093
[TBL] [Abstract] [Full Text] [Related]
14. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation.
Rezaei S; Nikpanjeh N; Rezaee A; Gholami S; Hashemipour R; Biavarz N; Yousefi F; Tashakori A; Salmani F; Rajabi R; Khorrami R; Nabavi N; Ren J; Salimimoghadam S; Rashidi M; Zandieh MA; Hushmandi K; Wang Y
Eur J Pharmacol; 2023 Sep; 955():175909. PubMed ID: 37490949
[TBL] [Abstract] [Full Text] [Related]
15. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
[TBL] [Abstract] [Full Text] [Related]
16. PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma.
Liu X; Pan YJ; Kang MJ; Jiang X; Guo ZY; Pei DS
Cell Signal; 2023 Oct; 110():110803. PubMed ID: 37437827
[TBL] [Abstract] [Full Text] [Related]
17. Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal.
Wei H; Li Z; Zhao Y; Zhu S; Wen S; Quan C
Cancer Rep (Hoboken); 2023 Aug; 6(8):e1824. PubMed ID: 37344930
[TBL] [Abstract] [Full Text] [Related]
18. Construction and validation of risk model of emt-related prognostic genes for kidney renal clear cell carcinoma.
Wu LL; Yuan SF; Lin QY; Chen GM; Zhang W; Zheng WE; Lin HL
J Gene Med; 2023 Nov; 25(11):e3549. PubMed ID: 37271571
[TBL] [Abstract] [Full Text] [Related]
19. ApoM suppresses kidney renal clear cell carcinoma growth and metastasis via the Hippo-YAP signaling pathway.
Xu T; Wei D; Yang Z; Xie S; Yan Z; Chen C; Hu W; Shi Z; Zhao Y; Cui M; Xu Z; Wang J
Arch Biochem Biophys; 2023 Jul; 743():109642. PubMed ID: 37211224
[TBL] [Abstract] [Full Text] [Related]
20. Risk signature identification and NPRL2 affects sunitinib sensitivity in clear cell renal cell carcinoma.
Du X; Zhao Z; Zhao X; Wang H; Jiang L; Tang W
Biochem Biophys Res Commun; 2023 Jun; 663():122-131. PubMed ID: 37121122
[TBL] [Abstract] [Full Text] [Related]
[Next]
